Inhibition of the mitochondrial pyruvate carrier attenuates the integrated stress response activation in a cellular model of Huntington’s disease

Ângela Oliveira, Liliana M. Almeida, Jorge M. A. Oliveira, Brígida R. Pinho · 2026

Read Inhibition of the mitochondrial pyruvate carrier attenuates the integrated stress response activation in a cellular model of Huntington’s disease by Ângela Oliveira, Liliana M. Almeida, Jorge M. A. Oliveira, Brígida R. Pinho (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13379411.txt.

Description

Ângela Oliveira, Liliana Almeida, Jorge Oliveira, and Brígida Pinho wrote this 2026 study on a possible drug target in Huntington's disease. The disease damages nerve cells over time and runs in families. A cell system called the integrated stress response, which normally helps cells survive strain, is out of balance in the disease.

Earlier work found that blocking a carrier that moves pyruvate into mitochondria protected cells in models of Alzheimer's and Parkinson's disease. Little was known about that carrier in Huntington's disease. The team treated cells that make fragments of either normal or mutant huntingtin protein. They used two drugs that block the carrier, plus a control. They then measured cell energy use, stress response signals, and how the mutant protein clumped. The question was whether blocking the carrier calms the stress response and cuts the harm of the mutant protein.

Catalog record

CREATORÂngela Oliveira, Liliana M. Almeida, Jorge M. A. Oliveira, Brígida R. Pinho
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13379411

Browse the full library · About the Tower of Babel